Moderna, Inc. (MRNA)
NASDAQ: MRNA · Real-Time Price · USD
23.56
-0.19 (-0.80%)
At close: Nov 5, 2025, 4:00 PM EST
23.75
+0.19 (0.81%)
After-hours: Nov 5, 2025, 7:59 PM EST
Moderna Stock Forecast
Stock Price Forecast
The 13 analysts that cover Moderna stock have a consensus rating of "Hold" and an average price target of $37.15, which forecasts a 57.68% increase in the stock price over the next year. The lowest target is $15 and the highest is $69.
Price Target: $37.15 (+57.68%)
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for Moderna stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | May '25 | Jun '25 | Jul '25 | Aug '25 | Sep '25 | Oct '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 13 | 13 | 13 | 12 | 12 | 8 |
| Sell | 3 | 3 | 3 | 4 | 4 | 4 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 19 | 19 | 19 | 19 | 19 | 15 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| UBS | UBS | Strong Buy Maintains $70 → $40 | Strong Buy | Maintains | $70 → $40 | +69.78% | Oct 23, 2025 |
| JP Morgan | JP Morgan | Sell Maintains $26 → $25 | Sell | Maintains | $26 → $25 | +6.11% | Oct 23, 2025 |
| Citigroup | Citigroup | Hold Maintains $30 → $28 | Hold | Maintains | $30 → $28 | +18.85% | Oct 23, 2025 |
| Needham | Needham | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Oct 20, 2025 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $31 → $32 | Hold | Maintains | $31 → $32 | +35.82% | Oct 10, 2025 |
Financial Forecast
Revenue This Year
1.93B
from 3.24B
Decreased by -40.27%
Revenue Next Year
2.15B
from 1.93B
Increased by 11.12%
EPS This Year
-9.93
from -9.28
EPS Next Year
-7.96
from -9.93
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 2.3B | 3.2B | |||
| Avg | 1.9B | 2.1B | |||
| Low | 1.5B | 1.3B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -28.8% | 63.8% | |||
| Avg | -40.3% | 11.1% | |||
| Low | -53.3% | -32.1% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -8.86 | -6.00 | |||
| Avg | -9.93 | -7.96 | |||
| Low | -10.50 | -9.93 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.